Diane M Otterness

Title: The Innovative Contributions of Diane M Otterness

Introduction

Diane M Otterness is a prominent inventor based in Rochester, MN (US). She has made significant contributions to the field of medical research, particularly in the area of genetic sequences and their implications for hormone-dependent diseases. With a total of 2 patents, her work has garnered attention for its potential impact on healthcare.

Latest Patents

Diane's latest patents include groundbreaking research on sulfotransferase sequence variants. This patent describes isolated sulfotransferase nucleic acid molecules that encompass a nucleotide sequence variant along with the nucleotides flanking the sequence variant. Additionally, it outlines methods for determining a risk estimate for hormone-dependent diseases and assessing sulfonator status. Another notable patent involves stably-transformed cells expressing human thiopurine methyltransferase (TPMT). This patent provides a recombinant DNA sequence that encodes human TPMT, along with a mammalian cell line that incorporates this sequence into its genome, enabling the cells to express high levels of human TPMT activity.

Career Highlights

Diane M Otterness is affiliated with the Mayo Foundation for Medical Education and Research, where she continues to advance her research and innovations. Her work is characterized by a commitment to improving medical outcomes through genetic research and innovative methodologies.

Collaborations

Diane has collaborated with esteemed colleagues such as Richard M Weinshilboum and Thomas C Wood. These partnerships have further enriched her research and contributed to the advancement of medical science.

Conclusion

Diane M Otterness exemplifies the spirit of innovation in medical research through her patents and collaborations. Her contributions are paving the way for advancements in understanding genetic factors related to health.